(Press-News.org) COLUMBUS, Ohio – A new study shows that it is possible to selectively target and block a particular microRNA that is important in liver cancer. The findings might offer a new therapy for this malignancy, which kills an estimated 549,000 people worldwide annually.
The animal study, by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) and at Mayo Clinic, focused on microRNA-221 (miR-221), a molecule that is consistently present at abnormally high levels in liver cancer.
To control the problem molecule, the researchers designed a second molecule as a kind of mirror image of the first. That mirror molecule is called an antisense oligonucleotide, and it selectively bound to and blocked the action of miR-221 in human liver cancer transplanted into mice. The treatment significantly prolonged the animals' lives and promoted the activity of important tumor-suppressor genes.
"This study is significant because hepatocellular carcinoma, or liver cancer, generally has a poor prognosis, so we badly need new treatment strategies," says principal investigator Thomas Schmittgen, associate professor and chair of pharmaceutics at Ohio State's College of Pharmacy and a member of the OSUCCC – James Experimental Therapeutics program.
The findings are published in the journal Cancer Research.
For the study, Schmittgen and his colleagues injected liver cancer cells labeled with the luminescent lighting-bug protein luciferase into the livers of mice. The researchers used bioluminescence imaging to monitor tumor growth.
When the tumors reached the appropriate size, they gave one group of animals the molecule designed to block miR-221; the other group received a control molecule.
Key findings include the following:
After treatment with the antisense oligonucleotide, half the treated animals were alive at 10 weeks versus none of the controls.
The antisense oligonucleotide significantly reduced levels of miR-221 in both tumor and normal liver samples.
Treatment with the antisense oligonucleotide caused a three-fold increase in the activity of three important tumor-suppressor genes that are blocked by miR-221 in liver cancer. (The tumor suppressors were p27, p57 and PTEN.)
"Overall, this study provides proof-of-principle for further development of microRNA-targeted therapies for hepatocellular carcinomas," Schmittgen says.
### END
Anti-sense might make sense for treating liver cancer
2012-01-05
ELSE PRESS RELEASES FROM THIS DATE:
ATS issues joint statement on key issues and recommendations for critical care research
2012-01-05
To reduce mortality and improve patient care in the nation's ICUs, a task force formed by the Critical Care Societies Collaborative (CCSC), in conjunction with the US Critical Illness and Injury Trials Group (USCIITG) has recommended that research in the field become less fragmented and better account for patient heterogeneity and the complexity of critical illness.
The CCSC comprises the American Thoracic Society (ATS), the American Association of Critical-Care Nurses (AACN), the American College of Chest Physicians (ACCP) the Society of Critical Care Medicine (SCCM). ...
Festival of Films Starts 2012 with All New Documentaries and Short Films Online
2012-01-05
Festival of Films has just announced its latest schedule of free indie films, documentaries and funny videos online for the first week of 2012. Available online at http://www.FestivalofFilms.com, the website serves as a resource for people looking to watch free full movies online and on their phones.
Festival of Films will start off the year with "Life in a Day," a 2011 documentary featuring an arrangement of user clips shot on June 24, 2010 and submitted via Youtube. Joining Festival of Films' selection of free documentaries online, "Life in a Day" ...
Oregon's program to improve care for those with advanced illness highlighted in JAMA
2012-01-05
PORTLAND, Ore. - Oregon's groundbreaking Physician Orders for Life Sustaining Treatment program (POLST) is featured in the latest edition of the Journal of The American Medical Association. The program, which was created by health care professionals two decades ago in an effort to ensure the wishes of those with advanced illness are followed, has now spread to 34 states around the country.
The program's key component is an order form that provides clear instruction about the patient's health care preferences to health professionals, such as paramedics and emergency room ...
BUSM researchers identify novel compound to halt virus replication
2012-01-05
(Boston) – A team of scientists from Boston University School of Medicine (BUSM) have identified a novel compound that inhibits viruses from replicating. The findings, which are published online in the Journal of Virology, could lead to the development of highly targeted compounds to block the replication of poxviruses, such as the emerging infectious disease Monkeypox.
The basic research was led by Ken Dower, PhD, a postdoctoral fellow in the laboratory of John Connor, PhD, assistant professor of microbiology at BUSM who is corresponding author on the paper. They worked ...
Weatherford International use ONELAN to Improve Communications
2012-01-05
One of the largest oilfield services companies, Weatherford International is headquartered in Switzerland, and currently operates in more than 100 countries across the world, employing more than 52,000 people. The company has regional hubs in major energy-producing regions such as Asia, Canada, Europe, Latin America, the Middle East, Russia, and the United States. Weatherford has a product and service portfolio that spans the life cycle of a well including drilling, evaluation, completion, production and intervention as well as research and development.
Weatherford selected ...
Bat brains parse sounds for multitasking
2012-01-05
Washington, D.C. – Imagine listening to music while carrying on a conversation with friends. This type of multi-tasking is fairly easy to do, right? That's because our brains efficiently and effectively separate the auditory signals – music to the right side; conversation to the left. But what researchers have not been able to do in humans or animals is to see a parsing of duties at the single neuron level – until now.
Publishing in the European Journal of Neuroscience, renowned bat researcher Jagmeet Kanwal, PhD, associate professor in the department of neurology at ...
Death rate measure used to judge hospital quality may be misleading
2012-01-05
Hospitals, health insurers and patients often rely on patient death rates in hospitals to compare hospital quality. Now a new study by researchers at Yale School of Medicine questions the accuracy of that widely used approach and supports measuring patient deaths over a period of 30 days from admission even after they have left the hospital.
Published in the Jan. 3 issue of Annals of Internal Medicine, the study has wide implications as quality measures take on more importance in the healthcare system, notes Elizabeth Drye, M.D., a research scientist at Yale School of ...
NAFA Explains Risk Management With New Webinar Series
2012-01-05
In a perfect world, businesses would never have to deal with uncertainty. Fleet managers, who have to face everything from monetary losses due to vehicles involved in crashes to the loss of life itself, realize this isn't a perfect world. Since it is neither possible nor practical to insure against every situation, it is up to the fleet manager to make sure their vehicles are safe, drivers are trained, and crashes are prevented. To help fleet managers learn more about risk management, NAFA Fleet Management Association is running a Risk Management 101 webinar series February ...
Home monitoring may help manage and reduce costs for heart failure
2012-01-05
Heart failure affects 5.8 million people in the U.S. alone and is responsible for nearly 1 million hospitalizations each year, most resulting from a build-up of body fluid in the lungs and other organs due to the heart's inability to pump effectively. The disease needs to be closely tracked in order to avoid such hospitalizations, and home-monitoring interventions may be especially useful, UCLA researchers say.
In their new paper, the UCLA authors discuss the importance of heart failure disease-management and early identification, as well as the treatment of body-fluid ...
Autism may be linked to abnormal immune system characteristics and novel protein fragment
2012-01-05
Tampa, FL (Jan 3, 2012) – Immune system abnormalities that mimic those seen with autism spectrum disorders have been linked to the amyloid precursor protein (APP), reports a research team from the University of South Florida's Department of Psychiatry and the Silver Child Development Center.
The study, conducted with mouse models of autism, suggests that elevated levels of an APP fragment circulating in the blood could explain the aberrations in immune cell populations and function – both observed in some autism patients. The findings were recently published online in ...